Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine

Front Neurol. 2016 Sep 30;7:167. doi: 10.3389/fneur.2016.00167. eCollection 2016.
No abstract available

Keywords: Alzheimer; actelylcholine; cognition enhancer; deficit model; memory.